Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 16,079 | 17,631 | 16,413 | 13,139 | 15,120 |
| Cost of Goods | 5,440 | 5,755 | 4,939 | 4,790 | 4,679 |
| Gross Profit | 10,639 | 11,876 | 11,474 | 8,349 | 10,441 |
| Operating Expenses | 15,699 | 19,442 | 48,886 | 31,456 | 35,050 |
| Operating Income | -4,620 | -6,811 | -36,473 | -22,317 | -23,930 |
| Interest Expense | 2,041 | 2,742 | 2,518 | 2,805 | 2,594 |
| Other Income | 618 | 18,406 | 27,337 | 431 | 453 |
| Pre-tax Income | -6,043 | 8,853 | -11,654 | -24,691 | -26,071 |
| Income Tax | -646 | 26 | N/A | N/A | 243 |
| Net Income Continuous | -5,397 | 8,827 | -11,654 | -24,691 | -26,314 |
| Minority Interests | -1,460 | 2,977 | -27,140 | -14,107 | -19,549 |
| Net Income | $-3,937 | $5,850 | $15,486 | $-10,584 | $-6,765 |
| EPS Basic Total Ops | -0.22 | 0.13 | 0.50 | -0.48 | -0.16 |
| EPS Basic Continuous Ops | -0.14 | 0.32 | -0.43 | -0.93 | -0.61 |
| EPS Diluted Total Ops | -0.15 | 0.11 | 0.45 | -0.48 | -0.16 |
| EPS Diluted Continuous Ops | -0.12 | 0.27 | -0.39 | -0.93 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.21 | 0.11 | -0.46 | -0.48 | -0.26 |
| EBITDA(a) | $-2,648 | $-4,839 | $-34,380 | $-20,346 | $-22,025 |